D. Peyramond

3.0k total citations
125 papers, 2.0k citations indexed

About

D. Peyramond is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, D. Peyramond has authored 125 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Infectious Diseases, 50 papers in Epidemiology and 26 papers in Public Health, Environmental and Occupational Health. Recurrent topics in D. Peyramond's work include HIV/AIDS drug development and treatment (17 papers), Streptococcal Infections and Treatments (14 papers) and HIV/AIDS Research and Interventions (14 papers). D. Peyramond is often cited by papers focused on HIV/AIDS drug development and treatment (17 papers), Streptococcal Infections and Treatments (14 papers) and HIV/AIDS Research and Interventions (14 papers). D. Peyramond collaborates with scholars based in France, United States and Canada. D. Peyramond's co-authors include A. Boibieux, F. Biron, Pierre‐Jean Weiller, François Janbon, H. Tissot Dupont, Philippe Brouqui, Meyer Nezri, C. Chicheportiche, R Poirier and Didier Raoult and has published in prestigious journals such as Blood, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

D. Peyramond

119 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Peyramond France 22 1.1k 772 373 304 275 125 2.0k
Ferrán Segura Spain 27 968 0.9× 400 0.5× 148 0.4× 389 1.3× 473 1.7× 71 1.7k
C. Michelet France 29 1.1k 1.0× 1.1k 1.4× 277 0.7× 147 0.5× 494 1.8× 94 2.5k
Norman Markowitz United States 23 1.7k 1.5× 1.2k 1.5× 242 0.6× 343 1.1× 620 2.3× 65 2.8k
Virat Sirisanthana Thailand 29 1.5k 1.3× 768 1.0× 388 1.0× 199 0.7× 656 2.4× 78 2.2k
Aba Mahamat France 22 495 0.4× 330 0.4× 251 0.7× 216 0.7× 186 0.7× 61 1.4k
Laurence Baril France 28 1.0k 0.9× 687 0.9× 740 2.0× 320 1.1× 254 0.9× 74 2.5k
Philippe Lepage Belgium 30 1.6k 1.4× 1.1k 1.5× 184 0.5× 90 0.3× 808 2.9× 81 2.9k
Glenn Wortmann United States 30 718 0.6× 1.1k 1.4× 951 2.5× 189 0.6× 268 1.0× 88 2.7k
Eduardo Martins Netto Brazil 29 1.2k 1.1× 1.4k 1.8× 1.3k 3.4× 265 0.9× 222 0.8× 175 3.2k
Miguel Górgolas Spain 25 1.2k 1.0× 986 1.3× 627 1.7× 133 0.4× 351 1.3× 149 2.4k

Countries citing papers authored by D. Peyramond

Since Specialization
Citations

This map shows the geographic impact of D. Peyramond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Peyramond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Peyramond more than expected).

Fields of papers citing papers by D. Peyramond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Peyramond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Peyramond. The network helps show where D. Peyramond may publish in the future.

Co-authorship network of co-authors of D. Peyramond

This figure shows the co-authorship network connecting the top 25 collaborators of D. Peyramond. A scholar is included among the top collaborators of D. Peyramond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Peyramond. D. Peyramond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blin, Patrick, Sylvie Blazejewski, S. Lignot, et al.. (2010). Effectiveness of antibiotics for acute sinusitis in real‐life medical practice. British Journal of Clinical Pharmacology. 70(3). 418–428. 10 indexed citations
2.
Boibieux, A., et al.. (2009). Toxoplasmose médullaire au cours de l’infection à VIH. Médecine et Maladies Infectieuses. 39(6). 401–405. 3 indexed citations
3.
Chidiac, Christian, Patrick Miailhes, Nicolas Voirin, et al.. (2008). Pneumococcal pneumonia in HIV‐infected patients by antiretroviral therapy periods. HIV Medicine. 9(4). 203–207. 18 indexed citations
4.
Valour, Florent, Laurence Maulin, Florence Ader, et al.. (2006). Vaccination contre la grippe : résultats d'une enquête sur la couverture vaccinale du personnel hospitalier à l'hôpital de la Croix-Rousse (hôpitaux de Lyon). Médecine et Maladies Infectieuses. 37(1). 51–60. 17 indexed citations
5.
Issartel, B., et al.. (2005). Tuberculomes et méningoradiculite tuberculeuse d’évolution paradoxale sous traitement. La Presse Médicale. 34(1). 32–34. 6 indexed citations
6.
Peyramond, D., et al.. (2004). Prevalence of Toxoplasma Encephalitis in AIDS Patients Treated with Didanosine Hospitalised in a French Infectious Service. Current HIV Research. 2(4). 301–307. 2 indexed citations
7.
8.
Peyramond, D., et al.. (2003). Impact of a Patient Education Program on Adherence to HIV Medication. JAIDS Journal of Acquired Immune Deficiency Syndromes. 34(2). 191–194. 130 indexed citations
9.
Issartel, B., et al.. (2002). Successful Treatment of Prosthetic Knee Infection due to Campylobacter upsaliensis. European Journal of Clinical Microbiology & Infectious Diseases. 21(3). 234–235. 9 indexed citations
10.
Brunet, Jean‐Luc, D. Peyramond, & G. Cozon. (2001). [Diagnosis of normal and abnormal delayed hypersensitivity to Candida albicans. Importance of evaluating lymphocyte activation by flow cytometry].. PubMed. 33(3). 115–9. 1 indexed citations
11.
Biron, F., et al.. (2000). Long-Term Safety and Antiretroviral Activity of Hydroxyurea and Didanosine in HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 25(4). 329–336. 15 indexed citations
12.
Durupt, S., A. Boibieux, G. Chaumentin, et al.. (1998). [Propionibacterium acnes infectious endocarditis].. PubMed. 27(36). 1839–41. 16 indexed citations
13.
Boibieux, A., Thierry Zénone, G. Chaumentin, et al.. (1997). Treatment of disseminated Mycobacterium simiae infection in AIDS. Clinical Microbiology and Infection. 3(2). 265–267. 3 indexed citations
14.
Biron, F., D. Peyramond, A. Frésard, et al.. (1996). Pilot clinical trial of the combination of hydroxyurea and didanosine in HIV-1 infected individuals. Antiviral Research. 29(1). 111–113. 23 indexed citations
15.
Peyramond, D., H. Portier, Pierre Geslin, & Robert Cohen. (1996). 6-Day Amoxicillin Versus 10-day Penicillin V for Group A β-Haemolytic Streptococcal Acute Tonsillitis in Adults: A French Multicentre, Open-label, Randomized Study. Scandinavian Journal of Infectious Diseases. 28(5). 497–501. 33 indexed citations
16.
Chaumentin, G., et al.. (1996). Trichosporon inkin Endocarditis: Short-Term Evolution and Clinical Report. Clinical Infectious Diseases. 23(2). 396–397. 23 indexed citations
17.
Dumontet, Charles, et al.. (1991). Acute Silicosis Due to Inhalation of a Domestic Product. American Review of Respiratory Disease. 143(4_pt_1). 880–882. 16 indexed citations
18.
Étard, Jean-François, et al.. (1987). [Q fever infectious endocarditis. 3 cases].. PubMed. 16(18). 902–5. 2 indexed citations
19.
Lucht, F., et al.. (1985). Abcès tuberculeux bilatéral du psoas sans atteinte rachidienne.. La Presse Médicale. 14(43). 2194–2194. 1 indexed citations
20.
Mercatello, A., et al.. (1984). OEdème pulmonaire lésionnel au cours d'une méningite à méningocoques. La Presse Médicale. 13(31). 1899–1899. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ferrán Segura Breakdown of academic impact, for papers by C. Michelet Breakdown of academic impact, for papers by Norman Markowitz Breakdown of academic impact, for papers by Virat Sirisanthana Breakdown of academic impact, for papers by Aba Mahamat Breakdown of academic impact, for papers by Laurence Baril Breakdown of academic impact, for papers by Philippe Lepage Breakdown of academic impact, for papers by Glenn Wortmann Breakdown of academic impact, for papers by Eduardo Martins Netto Breakdown of academic impact, for papers by Miguel Górgolas
Rankless by CCL
2026